目标血管及冠状动脉介入治疗对慢性完全闭塞病变长期预后的影响
本文选题:慢性完全闭塞病变 切入点:介入治疗 出处:《浙江大学》2015年博士论文 论文类型:学位论文
【摘要】:背景:慢性完全闭塞病变(CTO)在冠心病中发生率高,而目前经皮冠状动脉介入治疗(PCI)率仍低,除了受到技术难度和操作风险的限制,CTO-PCI临床获益的不确定性亦对治疗决策的选择造成困扰。虽然多数大型观察性研究已肯定了CTO-PCI的长期疗效,但仍不乏反对声音。随着介入技术的日新月异,对于CTO-PCI临床获益的结论需要与技术更新同步的数据支持。此外,已有前人研究提出CTO-PCI的生存获益因目标血管的不同而存在差异。本研究立足于明确CTO-PCI的长期临床获益,并尝试探讨开通不同部位CTO病变对于疗效影响的差异性。 方法:本研究收集了2006年9月至2011年12月,浙江大学医学院附属邵逸夫医院心内科收治的209名尝试经介入治疗开通单支CTO病变的患者信息,并排除了存在1月内急性心梗、左主干或桥血管慢性闭塞以及含多个CTO病变的患者。209人中,有183人通过了至少36个月的长期随访。本研究以主要不良心血管事件(MACE)(包括全因死亡、非致死性心梗和紧急目标血管血运重建)作为联合观察终点,比较了CTO-PCI成功与否对患者无MACE生存时间和择期再次血运重建的影响。 结果:209名患者中,右冠状动脉(RCA)病变者101人(48.3%),左前降支(LAD)病变者62人(29.7%),左回旋支(LCX)病变者有46人(22.0%)RCA CTO患者高血压发病率和既往行PCI治疗率更高,而LAD CTO患者中男性和吸烟者所占比例大。从冠脉造影特点来看,RCA CTO合并三支病变(80.2%vs.29.0%vs.66.0%, P0.001)及侧枝循环开放(72.2%vs.59.7%vs.42.0%,P=0.001)的比例显著高于LAD和LCX组。患者的总体造影成功率为79.4%,手术操作成功率为75.4%,不同目标血管分组间在造影和手术操作成功率上无显著差异。在平均44.6个月的随访中,手术操作成功能显著改善总体患者的无MACE生存时间(P0.001)。不同病变部位的亚组之间比较,仅RCA CTO患者PCI术显著延长无MACE生存时间(P0.001),而非RCA组中并无统计学差异(P=0.053)。经过Cox多元回归分析,手术操作成功仍是RCA CTO患者长期MACE的独立预测因子(HR3.30,95%CI:1.30-8.39, P=0.012) 结论:本研究结果提示CTO-PCI能显著改善长期无MACE生存情况,尤其对RCA病变患者获益更大。这一结论将有助于优化CTO-PCI的患者选择。
[Abstract]:Background: the incidence of chronic total occlusive lesions (CTO) in coronary heart disease is high, but the rate of percutaneous coronary intervention (PCI) is still low. In addition to being limited by technical difficulties and operational risks, the uncertainty of the clinical benefits of CTO-PCI also bothers the choice of treatment decisions, although most large observational studies have confirmed the long-term efficacy of CTO-PCI. But there is still a lot of opposition. With the rapid development of interventional techniques, conclusions about the clinical benefits of CTO-PCI need to be supported by data that are synchronized with technical updates. Previous studies have suggested that the survival benefits of CTO-PCI vary with the target vessels. This study is based on the long-term clinical benefits of CTO-PCI and attempts to explore the difference of the effect of opening different sites of CTO lesions on the efficacy. Methods: from September 2006 to December 2011, we collected information of 209 patients who were admitted to Department of Cardiology, affiliated to run run run Shaw Hospital, Zhejiang University Medical College, and excluded the presence of acute myocardial infarction within January. Of the .209 patients with chronic occlusion of the left main or graft vessels and with multiple CTO lesions, 183 passed at least 36 months of long-term follow-up. Non-fatal myocardial infarction and emergency target vascular revascularization) were used as the combined observation endpoints to compare the effects of CTO-PCI success on the survival time without MACE and recurrent revascularization. Results among the 209 patients, 101 patients had right coronary artery stenosis (RCA), 62 had left anterior descending artery (lad) lesions, and 46 had left circumflex branch (LCX) lesions. The incidence of hypertension and the rate of previous PCI treatment were higher in 46 patients with RCA CTO. However, the proportion of male and smoker in LAD CTO patients was higher than that in LAD and LCX groups. The ratio of RCA CTO with three vessel lesions was 80.2 vs 29.0vs.66.0 (P0.001) and 72.2 vs.59.7vs.42.0vs.42.0P0.001). The overall successful rate of angiography was 79.4%. The operative success rate was 75.4, and there was no significant difference between different target vessel groups in angiographic and operative success rates. The successful operation could significantly improve the survival time without MACE of the overall patients (P 0.001). Only PCI in patients with RCA CTO significantly prolonged the survival time without MACE (P 0.001), but there was no statistical difference in the non-#en4# group. By Cox multiple regression analysis, the success of the operation was still the independent predictor of long-term MACE in RCA CTO patients (HR3.30 ~ 95% CI: 1.30-8.39, P0. 012). Conclusion: the results of this study suggest that CTO-PCI can significantly improve the long-term MACE free survival, especially for the patients with RCA lesions. This conclusion will be helpful to optimize the choice of CTO-PCI patients.
【学位授予单位】:浙江大学
【学位级别】:博士
【学位授予年份】:2015
【分类号】:R541.4
【共引文献】
中国期刊全文数据库 前10条
1 苏胜;邱宁;张红;谭保平;王红;;糖尿病对老年冠状动脉慢性完全闭塞患者经皮介入治疗后的影响[J];介入放射学杂志;2013年09期
2 吴婷玉;张存泰;吴艳霞;;吡格列酮对急性心肌梗死小鼠心脏血管再生及心功能的影响[J];内科急危重症杂志;2013年06期
3 程如峰;丁宝玉;赵慧强;陈晖;;非ST段抬高心肌梗死患者的临床特征及影像特点[J];河北联合大学学报(医学版);2013年06期
4 盖兢泾;盖鲁粤;;冠状动脉慢性闭塞介入再通治疗及其对改善心功能和远期预后的疗效[J];中华保健医学杂志;2014年01期
5 孙家安;汝磊生;彭育红;张莉;赵玉英;王冬梅;;应用螺纹穿通导管治疗冠状动脉慢性完全闭塞病变[J];临床误诊误治;2014年04期
6 孙家安;汝磊生;彭育红;赵玉英;张莉;王冬梅;;血管内超声指导导丝通过技术开通冠状动脉慢性闭塞性病变[J];临床心血管病杂志;2014年07期
7 黎国德;许庆波;梁岩;叶海鹏;陈杰山;;Finecross微导管在冠状动脉慢性完全闭塞病变介入治疗中的应用[J];岭南心血管病杂志;2014年04期
8 侯方杰;邢明青;戴红艳;王晏平;管军;;瑞舒伐他汀对冠状动脉侧枝循环形成的影响[J];中国动脉硬化杂志;2014年12期
9 邱茹洁;张存泰;徐承义;何蕾;刘成伟;吴明祥;;老年冠心病患者冠状动脉慢性完全闭塞病变介入治疗及预后分析[J];内科急危重症杂志;2015年01期
10 杨素英;;阻塞性睡眠呼吸暂停低通气综合症血管损伤发病机制的研究进展[J];临床肺科杂志;2015年03期
中国重要会议论文全文数据库 前2条
1 林晓强;朱海;詹源胜;;成功开通慢性完全闭塞冠状动脉病变血管能提高患者的生存率[A];全国第十三届心脏学会、第十六届心功能专业委员会和《心脏杂志》编委会联合学术大会会议纪要[C];2013年
2 刘志华;;自主神经系统与心律失常[A];全国疑难急诊心电图学和心律失常诊疗新进展专题会议(2013)资料汇编[C];2013年
中国博士学位论文全文数据库 前6条
1 裴汉军;经导管主动脉瓣、冠状动脉介入治疗[D];北京协和医学院;2013年
2 况立洪;转录因子Nrf2对大鼠心肌微血管内皮细胞在血管生成中作用的影响及其机制的体外研究[D];第三军医大学;2013年
3 于君;正中神经调控抑制室性心律失常的实验研究[D];北京协和医学院;2014年
4 余晓玲;中国汉族人群心脏自主神经功能的参考值探讨及影响因素分析[D];复旦大学;2013年
5 袁敏杰;无创心电标志对急性冠脉综合征患者的预后价值[D];上海交通大学;2014年
6 孙振;稳定型心绞痛伴慢性冠状动脉阻塞患者和急性下肢缺血动物模型侧支循环研究[D];上海交通大学;2014年
,本文编号:1596037
本文链接:https://www.wllwen.com/yixuelunwen/xxg/1596037.html